A detailed history of Chilton Capital Management LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Chilton Capital Management LLC holds 300 shares of TMDX stock, worth $21,441. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Holding current value
$21,441
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$59.28 - $144.9 $17,784 - $43,470
300 New
300 $18,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.27B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Chilton Capital Management LLC Portfolio

Follow Chilton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.